Development of the Beta prototype (WP3) Sample Clauses

Development of the Beta prototype (WP3). The development and submission of the Beta version of the system is particularly crucial for the successful completion of the project. Further delays could potentially endanger the overall project. The consortium should pay particular attention to the following aspects:  Developing and releasing the initial version of the Beta prototype (Beta part 1) by Month 18 and the full Beta version (Beta part 2) by Month 22. This is particularly crucial to ensure sufficient time is allocated to proper testing with real users. The full Beta prototype (Beta part 2) should be developed by early September (Month 22) the latest to complete the piloting with users, as well as to allow the deployment of the system by associated partners (WP4) and to fine-tuning the system based on pilot results before the end of the project.
AutoNDA by SimpleDocs
Development of the Beta prototype (WP3). The development and submission of the Beta version of the system is particularly crucial for the successful completion of the project. Further delays could potentially endanger the overall project. The consortium should pay particular attention to the following aspects: • Developing and releasing the initial version of the Beta prototype (Beta part 1) by Month 18 and the full Beta version (Beta part 2) by Month 22. This is particularly crucial to ensure sufficient time is allocated to proper testing with real users. The full Beta prototype (Beta part 2) should be developed by early September (Month 22) the latest to complete the piloting with users, as well as to allow the deployment of the system by associated partners (WP4) and to fine-tuning the system based on pilot results before the end of the project. • Detailing the criteria adopted for selecting key functionalities to be developed in the Beta version. The consortium should document and describe in detail which functionalities presented in the framework architecture will be included in Beta part 1 and which additional functionalities will be developed in the Beta part 2, as well as what were the criteria adopted for selecting such functionalities. Among others, selection criteria should include: (1) functionalities reflecting/addressing the project objectives described in the Grant Agreement - Description of the Action; (2) functionalities that build upon / link to existing national services; (3) functionalities/data already present/available in the countries of Associated Partners. A clear mapping between the architecture functionalities included in the Beta versions and project objectives (as defined in the Grant Agreement- Description of the Action) should also be presented.

Related to Development of the Beta prototype (WP3)

  • DEVELOPMENT OR ASSISTANCE IN DEVELOPMENT OF SPECIFICATIONS REQUIREMENTS/ STATEMENTS OF WORK Firms and/or individuals that assisted in the development or drafting of the specifications, requirements, statements of work, or solicitation documents contained herein are excluded from competing for this solicitation. This shall not be applicable to firms and/or individuals providing responses to a publicly posted Request for Information (RFI) associated with a solicitation.

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones)

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Innovative Scheduling Schedules which are inconsistent with the Collective Agreement provisions may be developed in order to improve quality of working life, support continuity of resident care, ensure adequate staffing resources, and support cost-efficiency. The parties agree that such innovative schedules may be determined locally by the Home and the Union subject to the following principles:

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Commercialization Plan On a Product by Product basis, not later than sixty (60) days after the filing of the first application for Regulatory Approval of a Product in the Copromotion Territory, the MSC shall prepare and approve a rolling multiyear (not less than three (3) years) plan for Commercializing such Product in the Copromotion Territory (the "Copromotion Territory Commercialization Plan"), which plan includes a comprehensive market development, marketing, sales, supply and distribution strategy for such Product in the Copromotion Territory. The Copromotion Territory Commercialization Plan shall be updated by the MSC at least once each calendar year such that it addresses no less than the three (3) upcoming years. Not later than thirty (30) days after the filing of the first application for Regulatory Approval of a Product in the Copromotion Territory and thereafter on or before September 30 of each calendar year, the MSC shall prepare an annual commercialization plan and budget (the "Annual Commercialization Plan and Budget"), which plan is based on the then current Copromotion Territory Commercialization Plan and includes a comprehensive market development, marketing, sales, supply and distribution strategy, including an overall budget for anticipated marketing, promotion and sales efforts in the upcoming calendar year (the first such Annual Development Plan and Budget shall cover the remainder of the calendar year in which such Product is anticipated to be approved plus the first full calendar year thereafter). The Annual Commercialization Plan and Budget will specify which Target Markets and distribution channels each Party shall devote its respective Promotion efforts towards, the personnel and other resources to be devoted by each Party to such efforts, the number and positioning of Details to be performed by each Party, as well as market and sales forecasts and related operating expenses, for the Product in each country of the Copromotion Territory, and budgets for projected Pre-Marketing Expenses, Sales and Marketing Expenses and Post-Approval Research and Regulatory Expenses. In preparing and updating the Copromotion Territory Commercialization Plan and each Annual Commercialization Plan and Budget, the MSC will take into consideration factors such as market conditions, regulatory issues and competition.

  • Access Toll Connecting Trunk Group Architecture 9.2.1 If CBB chooses to subtend a Verizon access Tandem, CBB’s NPA/NXX must be assigned by CBB to subtend the same Verizon access Tandem that a Verizon NPA/NXX serving the same Rate Center Area subtends as identified in the LERG.

  • Curriculum Development This includes the analysis and coordination of textual materials; constant review of current literature in the field, some of which are selected for the college library collection, the preparation of selective, descriptive materials such as outlines and syllabi; conferring with other faculty and administration on curricular problems; and, the attendance and participation in inter and intra-college conferences and advisory committees.

  • Telemedicine Services This plan covers clinically appropriate telemedicine services when the service is provided via remote access through an on-line service or other interactive audio and video telecommunications system in accordance with R.I. General Law § 27-81-1. Clinically appropriate telemedicine services may be obtained from a network provider, and from our designated telemedicine service provider. When you seek telemedicine services from our designated telemedicine service provider, the amount you pay is listed in the Summary of Medical Benefits. When you receive a covered healthcare service from a network provider via remote access, the amount you pay depends on the covered healthcare service you receive, as indicated in the Summary of Medical Benefits. For information about telemedicine services, our designated telemedicine service provider, and how to access telemedicine services, please visit our website or contact our Customer Service Department.

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time.

Time is Money Join Law Insider Premium to draft better contracts faster.